FDA Inspection 1093003 — Richard F. Harty, M.D.
The FDA completed an inspection of Richard F. Harty, M.D. on May 16, 2019 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 16, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)
Additional Details
Clinical Investigator (CI)